ID   NCC-aRMS1-C1
AC   CVCL_A1ST
DR   Wikidata; Q105510286
RX   PubMed=32715445;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 61 hours (PubMed=32715445).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8621; PAX7; Name(s)=PAX7-FOXO1 (PubMed=32715445).
CC   Derived from site: In situ; Thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=32715445
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D21S11: 29,31.2
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
RX   PubMed=32715445; DOI=10.1007/s13577-020-00403-0;
RA   Sin Y., Yoshimatsu Y., Noguchi R., Tsuchiya R., Sei A., Ono T.,
RA   Toki S., Kobayashi E., Arakawa A., Sugiyama M., Yoshida A., Kawai A.,
RA   Kondo T.;
RT   "Establishment and characterization of a novel alveolar
RT   rhabdomyosarcoma cell line, NCC-aRMS1-C1.";
RL   Hum. Cell 33:1311-1320(2020).
//